Background:
The optimal mechanical circulatory support strategy for patients undergoing high-risk percutaneous coronary intervention (PCI) remains uncertain. Randomized trials evaluating elective intra-aortic balloon pump (IABP), Impella, and standard care have reported conflicting results and have not been synthesi...
R. Falodia, Ehsanullah Alokozay, Qasim Manzoor Amjad et al.· Circulation· 0 citations
Introduction:
Baxdrostat is a selective aldosterone synthase (CYP11B2) inhibitor evaluated in three phase 2/3 randomized controlled trials (RCTs) for treatment-resistant and uncontrolled hypertension. However, no dedicated quantitative synthesis has characterized its blood pressure-lowering efficacy, dose-response r...
Background:
Fatty change of the liver is strongly associated with cardiovascular risk due to insulin resistance, dyslipidemia, and systemic inflammation. GLP-1 receptor agonists (GLP-1 RAs) and SGLT2 inhibitors (SGLT2is) each provide independent cardiovascular benefits. This study assesses whether combination therap...
M. Azhar, Aneesa Altaf, Ehsanullah Alokozay et al.· Circulation· 0 citations
Strict on-site coverage of critical-care physician coverage did not significantly reduce hospital mortality, and available studies cannot reliably isolate added benefit beyond existing ICU support, which does not question the importance of specialist critical-care expertise.
K. Razvi, U. Irshad, Muhammad Abdullah et al.· Journal of critical care· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.